• Is 340B Program Management Leaving You Fragmented?

    RxStrategies 340BPlus Split Billing Solution helps to remove the complexity of 340B program management by reviewing all prescription activity to flag eligible 340B dispenses. All activity is then designated for proper replenishment, (GPO, WAC, 340B) auditability and reporting.   RxStrategies’ 340BPlus Split Billing Solution:   Maximizes your savings by assuring data integrity via an automated… Read more »

  • RxStrategies Clinical Insights — September 2015 Issue 1

    Welcome to the first September edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Xuriden™ (uridine triacetate) September 4, 2015 — The U.S. Food and Drug Administration approved Xuriden™ (uridine triacetate), the first FDA-approved treatment for patients with… Read more »